Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva's flagship drug Austedo scores new approval at the FDA
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
teva News and latest stories | The Jerusalem Post
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva shares surge after announcing global opioid settlement
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva Pharmaceuticals (@TevaUSA) / Twitter
New York could get $524M under opioid settlements with Teva - ABC News
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva x Sankuanz Team Up for Hurricane Sandal at Opening Ceremony – Footwear News
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva looks to amp up research collaborations, CEO says
Allergan on $40.5 Billion Drug Deal - The New York Times
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva CEO Schultz likely won't renew employment contract: reports
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Pharmaceutical's Sales Slump 18% - WSJ
